DocSym
β
Searchsearch
Search
(H22.0*) Iridocyclitis in infectious and parasitic diseases classified elsewhere
More details coming soon
NaN% mortality rate associated with the disease iridocyclitis in infectious and parasitic diseases classified elsewhere
Diagnosis iridocyclitis in infectious and parasitic diseases classified elsewhere is diagnosed Prevalent in Women Only
0
Men receive the diagnosis iridocyclitis in infectious and parasitic diseases classified elsewhere
0 (No mortality)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
0
Women receive the diagnosis iridocyclitis in infectious and parasitic diseases classified elsewhere
0 (No mortality)Died from this diagnosis.
Risk Group for the Disease iridocyclitis in infectious and parasitic diseases classified elsewhere - Men and Women aged 0
No Cases of the Disease Iridocyclitis in infectious and parasitic diseases classified elsewhere identified in Men
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-95+
No Cases of the Disease Iridocyclitis in infectious and parasitic diseases classified elsewhere identified in Men
Disease Features iridocyclitis in infectious and parasitic diseases classified elsewhere
Absence or low individual and public risk
Iridocyclitis in infectious and parasitic diseases classified elsewhere - what does this mean
Iridocyclitis in infectious and parasitic diseases classified elsewhere is an inflammatory eye condition caused by the spread of an infection or parasite to the eye. it is characterized by redness, pain, blurred vision, and light sensitivity. it can be caused by a variety of pathogens, including bacteria, fungi, viruses, and parasites, and can lead to serious complications if left untreated.
What happens during the disease - iridocyclitis in infectious and parasitic diseases classified elsewhere
Iridocyclitis is an inflammatory disease of the iris and ciliary body caused by an infectious agent, such as bacteria, viruses, fungi, or parasites. the infection can spread through the bloodstream and lymphatic system, or through direct contact with the eye. it can lead to swelling, redness, and pain in the eye, as well as vision changes, light sensitivity, and blurred vision. treatment typically includes antibiotics, steroids, or other medications to reduce inflammation and pain, as well as to treat the underlying cause of the infection.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the eye
- Ophthalmoscopy
- Slit-lamp examination
- Tonometry
- Ultrasound imaging of the eye
- CT scan of the eye
- MRI of the eye
- Blood tests to check for inflammation markers
- Culture of any fluid from the eye
- Serological tests to detect the presence of antibodies
Treatment and Medical Assistance
Main Goal: To reduce the inflammation and pain associated with Iridocyclitis.
- Administering topical corticosteroids
- Prescribing oral nonsteroidal anti-inflammatory drugs
- Prescribing antibiotics to treat any underlying infection
- Prescribing antifungal medication to treat any underlying fungal infection
- Prescribing antiparasitic medication to treat any underlying parasitic infection
- Prescribing topical cycloplegic agents to reduce pain and inflammation
- Prescribing immunosuppressant drugs to reduce inflammation
- Prescribing topical mydriatics to dilate the pupil
- Performing laser surgery to reduce inflammation
- Performing surgical removal of the affected eye tissue
No Hospitalization Required
Average Time for Outpatient Care Not Established
Iridocyclitis in infectious and parasitic diseases classified elsewhere - Prevention
The best way to prevent iridocyclitis in infectious and parasitic diseases classified elsewhere is to practice good hygiene, such as washing your hands frequently, avoiding contact with people who are ill, and using insect repellent to avoid insect-borne diseases. additionally, getting vaccinated against certain diseases and taking medications as prescribed can help reduce the risk of iridocyclitis.